Anticoagulants
Read the topic background here, then explore the labeled visual and structured learning explanations on this page.
Read explanation on this page ↓ See diagram ↓Anticoagulant — on-site reading
This reference extract addresses Anticoagulant, a related subject. It does not cover every part of Anticoagulants.. The article introduction is reproduced here, so you do not need to leave MedAtlas to read it. It may not match the latest official medical guidance.
An anticoagulant, commonly known as a blood thinner, is a chemical substance that prevents or reduces the coagulation of blood, prolonging the clotting time. Some occur naturally in blood-eating animals, such as leeches and mosquitoes, which help keep the bite area unclotted long enough for the animal to obtain blood.
As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as sample tubes, blood transfusion bags, heart–lung machines, and dialysis equipment. One of the first anticoagulants, warfarin, was initially approved as a rodenticide.
Anticoagulants are closely related to antiplatelet drugs and thrombolytic drugs by manipulating the various pathways of blood coagulation. Specifically, antiplatelet drugs inhibit platelet aggregation (clumping together), whereas anticoagulants inhibit specific pathways of the coagulation cascade, which happens after the initial platelet aggregation but before the formation of fibrin and stable aggregated platelet products.
Common anticoagulants include warfarin and heparin.
How this connects to Pharmacology
Blood and marrow disorders involve cell production and survival, immune function or the regulation of clotting and bleeding. A blood count or isolated biomarker is not a diagnosis: peripheral smear findings, cell lineage, clinical history and relevant marrow or molecular tests may be necessary.
Text credit: Wikipedia contributors, “Anticoagulant”, original article · authors & revision history · CC BY-SA 4.0. Unmodified opening extract, accessed 24 September 2026. This Wikipedia-derived section is provided under CC BY-SA 4.0; the independent MedAtlas notes and design are separate works.
Anticoagulants · visual study map
Scalable vector illustration. Labeled conceptual map, not a precise anatomical, histological or diagnostic image.The wording in this learning map is adapted from the attributed Wikipedia background section below (CC BY-SA 4.0).
What the underlying subject studies
Pharmacology links a substance’s mechanism to the concentration reaching its target and the resulting physiological effect. Distinguish pharmacokinetics—how exposure changes—from pharmacodynamics—how a target responds.
How mechanisms and evidence connect
Benefits and harms depend on indication, route, dose, patient characteristics, organ function and interactions. A mechanism chart groups medicines for study but does not establish equivalence, superiority or an individual prescription.
How to develop a sound explanation
For each drug or drug class, identify the molecular target, intended effect, major limitations, common classes of adverse effects and how evidence and guidelines inform use. This library intentionally does not provide patient-specific doses or prescribing orders.
References and verification (optional)
All reading material on this page appears above. The links below are for checking the primary syllabus, research or source attribution, not requirements for opening this lesson.
NMC official CBME Curriculum 2024 and current regulations index ↗